Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
Public ClinicalTrials.gov record NCT01374490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-Label Evaluation of the Safety and Tolerability of Crofelemer in HIV-Positive Subjects With Diarrhea
Study identification
- NCT ID
- NCT01374490
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Interventions
- Crofelemer Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 6, 2011
- Primary completion
- Oct 30, 2012
- Completion
- Oct 30, 2012
- Last update posted
- Aug 30, 2020
2011 – 2012
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85006 | — |
| Not listed | Little Rock | Arkansas | 72207 | — |
| Not listed | Bakersfield | California | 93301 | — |
| Not listed | Beverly Hills | California | 90211 | — |
| Not listed | Los Angeles | California | 90015 | — |
| Not listed | San Diego | California | 92120 | — |
| Not listed | Fort Lauderdale | Florida | 33308 | — |
| Not listed | Fort Lauderdale | Florida | 33316 | — |
| Not listed | Miami | Florida | 33180 | — |
| Not listed | Miami Beach | Florida | 33139 | — |
| Not listed | Wilton Manors | Florida | 33305 | — |
| Not listed | Atlanta | Georgia | 30318 | — |
| Not listed | Chicago | Illinois | 60607 | — |
| Not listed | Chicago | Illinois | 60654 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | Santa Fe | New Mexico | 87505 | — |
| Not listed | New York | New York | 10018 | — |
| Not listed | Rochester | New York | 14607 | — |
| Not listed | Cincinnati | Ohio | 45267 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01374490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01374490 live on ClinicalTrials.gov.